Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Samuel Legeay"'
Autor:
Ling Jing Li, Samuel Legeay, Ann-Lorie Gagnon, Marie-Pier Frigon, Laurence Tessier, Karine Tremblay
Publikováno v:
Frontiers in Genetics, Vol 14 (2024)
Clinical implementation of pharmacogenetics (PGx) into routine care will elevate the current paradigm of treatment decisions. However, while PGx tests are increasingly becoming reliable and affordable, several barriers have limited their widespread u
Externí odkaz:
https://doaj.org/article/9753029b7c284468985ed4e9216ada15
Autor:
Julien Gouju, Samuel Legeay
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 166, Iss , Pp 115281- (2023)
Obesity is a pathophysiological state defined by a body mass index > 30 kg/m2 and characterized by an adipose tissue accumulation leading to an important weight increased. Several pathologies named comorbidities such as cardiovascular disease, type 2
Externí odkaz:
https://doaj.org/article/0167c9af396b4fb98456938f122b73ea
Autor:
Samuel Legeay, Pierre Fautrat, J. Blake Norman, Galina Antonova, Simone Kennard, Thiago Bruder-Nascimento, Vijay S. Patel, Sebastien Faure, Eric J. Belin de Chantemèle
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 127, Iss , Pp 110200- (2020)
Diabetes notably increases the risk for endothelial dysfunction, a main precursor for microvascular complications. While endoplasmic reticulum stress (ERS) and protein tyrosine phosphatase 1B (PTP1B) have been associated with endothelial dysfunction
Externí odkaz:
https://doaj.org/article/287881968a2845e593d1f24fd9509774
Autor:
Norraseth Kaeokhamloed, Emillie Roger, Jérôme Béjaud, Nolwenn Lautram, Florence Manero, Rodolphe Perrot, Marie Briet, Chadi Abbara, Samuel Legeay
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 595 (2021)
Standard models used for evaluating the absorption of nanoparticles like Caco-2 ignore the presence of vascular endothelium, which is a part of the intestinal multi-layered barrier structure. Therefore, a coculture between the Caco-2 epithelium and H
Externí odkaz:
https://doaj.org/article/d205ce3c2445475c8ccc39dac900cb2c
Autor:
Samuel Legeay, Sébastien Faure
Publikováno v:
Actualités Pharmaceutiques. 62:17-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a9bf9fe4534a1d66a3659786b785f39
https://doi.org/10.1016/j.actpha.2023.03.010
https://doi.org/10.1016/j.actpha.2023.03.010
Autor:
Samuel Legeay, Sébastien Faure
Publikováno v:
Actualités Pharmaceutiques. 62:15-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::383d2451881b6a26e22b01e033dda2c1
https://doi.org/10.1016/j.actpha.2023.01.032
https://doi.org/10.1016/j.actpha.2023.01.032
Autor:
Samuel Legeay, Sébastien Faure
Publikováno v:
Actualités Pharmaceutiques. 62:17-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42e9400fb853adea8145da6f407136ba
https://doi.org/10.1016/j.actpha.2022.11.004
https://doi.org/10.1016/j.actpha.2022.11.004
Autor:
Samuel Legeay, Sébastien Faure
Publikováno v:
Actualités Pharmaceutiques. 61:15-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::354c99d6064beca86f20ba4865f0cb49
https://doi.org/10.1016/j.actpha.2022.07.035
https://doi.org/10.1016/j.actpha.2022.07.035
Autor:
Soudeh F. Tehrani, Jean-Michel Rabanel, Samuel Legeay, Jérôme Cayon, Jérémie Riou, Patrick Saulnier, Sylvie Marleau, V. Gaëlle Roullin, Patrice Hildgen, Guillaume Bastiat
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics
European Journal of Pharmaceutics and Biopharmaceutics, In press, ⟨10.1016/j.ejpb.2022.04.003⟩
European Journal of Pharmaceutics and Biopharmaceutics, In press, ⟨10.1016/j.ejpb.2022.04.003⟩
International audience; Polymer nanoparticles (NPs) are extensively studied as drug delivery systems for various therapeutic indications, including drug and imaging agent delivery to the brain. Despite intensive research, their toxicological profile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dbe60222d509f64bee51213c0ee3773
https://doi.org/10.1016/j.ejpb.2022.04.003
https://doi.org/10.1016/j.ejpb.2022.04.003
Autor:
Samuel Legeay, Sébastien Faure
Publikováno v:
Actualités Pharmaceutiques. 61:15-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4f1e7d36dc07090f094404ceb5e127d
https://doi.org/10.1016/j.actpha.2022.05.004
https://doi.org/10.1016/j.actpha.2022.05.004